Digestive Tumors Unit
What does the Unit treat?
The Digestive Tumors Unit of HM CIOCC is an international reference in the treatment of pancreatic cancer, biliary tract cancer, colorectal tumors, and other digestive tumors.
At HM Hospitals (CIOCC), the Digestive Tumors Unit focuses on:
- Design of proprietary trials that have changed the treatment of pancreatic cancer worldwide.
- Development of research projects focused on optimizing treatments.
Detection of minimal residual tumor disease by liquid biopsy techniques.
Related Diseases
- Pancreatic Cancer.
- Liver Cancer.
- Esophageal Cancer.
- Stomach Cancer.
- Hepatocellular Carcinoma.
- Colon Cancer.
Who is this Unit for?
The Digestive Tumors Unit is aimed at:
- Patients with pancreatic cancer, biliary tract cancer, colorectal tumors, and other digestive tumors.
- Patients seeking innovative and personalized treatments for their type of cancer.
- Patients interested in participating in clinical trials to improve treatment options.
- Family members and caregivers seeking information and support for their loved ones with digestive cancer.
- Healthcare professionals who wish to refer patients for specialized digestive tumors evaluation and treatment.
How do we approach it at HM Hospitals?
Personalized treatment
The Digestive Tumors Area offers personalized treatment plans that may include surgery, chemotherapy, radiotherapy, targeted therapies, and immunotherapy, adapted to the specific characteristics of each patient and their tumor.